Cargando…

Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma

Detalles Bibliográficos
Autor principal: Tsang, Vivian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093315/
https://www.ncbi.nlm.nih.gov/pubmed/25031945
_version_ 1782325701470322688
author Tsang, Vivian
author_facet Tsang, Vivian
author_sort Tsang, Vivian
collection PubMed
description
format Online
Article
Text
id pubmed-4093315
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-40933152014-07-16 Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Tsang, Vivian J Adv Pract Oncol Review Article Harborside Press 2012 2012-05-01 /pmc/articles/PMC4093315/ /pubmed/25031945 Text en Copyright © 2012, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
Tsang, Vivian
Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
title Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
title_full Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
title_fullStr Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
title_full_unstemmed Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
title_short Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
title_sort brentuximab vedotin in hodgkin lymphoma and anaplastic large cell lymphoma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093315/
https://www.ncbi.nlm.nih.gov/pubmed/25031945
work_keys_str_mv AT tsangvivian brentuximabvedotininhodgkinlymphomaandanaplasticlargecelllymphoma